GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....

&GkB> GKB Ophthalmics Ltd. TR T 16-A, Tivim Industrial Estate, Mapusa, Goa 403 526 (INDIA) E-mail : gkbophthalmics@gkb.net CIN.: L26109GA1981PLC000469 Website : www.gkb.net GKB /STK-EXCH Department of Corporate Services BSE Limited Phiroze Jeejubhoy Towers Dalal Street Mumbai - 400 001 Dear Sir, Ref: Scrip Code N:o 533.212 Sub: Board Meeting for approval of Unaudited Standalone and_Consolidated Financial Results for the quarter ended June 30, 2026. Notice is hereby given pursuant to Regulation 29 read with Regulation 47 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a Meeting of the Board of Directors of the Company will be held on Wednesday, August 12, 2026 at the Registered Office of the Company, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026. The Notice can be accessed at the Company's website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, had been closed from July 01, 2026, will now re-open after the completion of 48 hours from the date of submission of financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company. Regd. Office For GKB Ophthalmics Ltd., 16-A, Tivim Industrial Estate Mapusa, Goa %,,Mfl,\ Pooja Dessai Date: July 25, 2026 Company Secretary